Infant, Child, and Maternal Probiotic Supplements Market to 2028
The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.
Probiotics are live bacteria and/or yeast, which benefit the person's gut health. Various benefits of probiotic supplements include boosting the gut microbiome, restoring balance to the microbiome, and supporting the immune system. Such benefits have surged its use among the target audience, which includes infants, children, and maternal women. Parents are increasingly focusing on their child’s nutrition and well-being, driving the market. Also, the increasing adoption of probiotic supplements among pregnant women has boosted the market substantially. Constant R&D taking place in this category across the globe will uplift the market growth in the coming years
In 2020, North America held the largest share of the global infant, child, and maternal probiotic supplements market, and Asia Pacific is estimated to register the fastest CAGR during the forecast period. Rising population, economic development, and an increase in disposable income are some factors contributing to the market's growth. Population in emerging economies, such as India, China, and Japan, are adopting nutritional supplements to improve the growth and development of children. Moreover, the increased infant mortality rate in emerging economies has fueled the demand for probiotic supplements in the region. For instance, according to the World Bank, in 2020, the infant mortality rate in East Asia Pacific was 11 per 1,000 live births.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infant, Child, and Maternal Probiotic Supplements Market: Strategic Insights
Market Size Value in US$ 604.94 Million in 2021 Market Size Value by US$ 1,081.70 Million by 2028 Growth rate CAGR of 8.7% from 2022 to 2028 Forecast Period 2022-2028 Base Year 2021
Shejal
Have a question?
Shejal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infant, Child, and Maternal Probiotic Supplements Market: Strategic Insights
| Market Size Value in | US$ 604.94 Million in 2021 |
| Market Size Value by | US$ 1,081.70 Million by 2028 |
| Growth rate | CAGR of 8.7% from 2022 to 2028 |
| Forecast Period | 2022-2028 |
| Base Year | 2021 |
Shejal
Have a question?
Shejal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market
Before the onset of the COVID-19 pandemic, the infant, child, and maternal probiotic supplements market was mainly driven by the rising focus of parents on specific infant nutrition and the increasing demand for nutritional supplements tailored according to the needs of pregnant women. However, the market faced unprecedented challenges after the outbreak in 2020. Manufacturers of infant, child, and maternal probiotic supplements faced significant challenges due to supply chain constraints caused by nationwide lockdowns, trade bans, and travel restrictions. Supply chain disruptions created a shortage of raw materials, which affected the production and distribution of various products, leading to increased prices.
In 2021, various economies resumed operations as governments announced relaxation in the previously imposed restrictions, which boosted the global market. Moreover, production facilities were permitted to operate at full capacity, which helped them overcome the demand and supply gap and other repercussions. As numerous citizens of many countries were fully vaccinated by 2021, market players focused on increasing their production to revive their businesses.
Market Insights
Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women to Drive Infant, Child, and Maternal Probiotic Supplements Market
Probiotics lower the risk of pre-eclampsia in pregnant women, a health condition resulting in high blood pressure and high protein levels in urine. Probiotic supplements also ensure better immunity for pregnant women, which helps fight chronic diseases and ensure the baby's good health. Lactobacillus acidophilus, Bifidobacterium bifidum, and Saccharomyces boulardii are among the most effective and widely used probiotic strains in prenatal probiotic supplements. These strains help to maintain a healthy intestinal flora and reduce the risk of various allergies, diseases, and complications, including gestational diabetes and pre-eclampsia. The growing awareness about the benefits of probiotic supplements among pregnant women is substantially driving the infant, child, and maternal probiotic supplements market.
Form Insights
Based on form, the infant, child, and maternal probiotic supplements market is categorized into capsules and softgels, gummies, liquid, and others . The others segment held the largest share in the market during the forecast period. However, the gummies segment is expected to register the highest CAGR during the forecast period. Sweet and easy-to-consume probiotic gummies are available in appealing colors and shapes (such as teddy bears) and various flavors. Several manufacturers are engaged in product innovations to meet the growing demands of adults and children. Such strategic developments by manufacturers to diversify their product range is likely to propel the demand for infant, child, and maternal probiotic supplement gummies in the coming years.
End User Insights
Based on End User, the infant, child, and maternal probiotic supplements market is segmented into infants and toddlers, children, and maternal women. The children segment accounted for the largest market share in 2020. Probiotic supplements are gaining popularity in these children as they play a vital role in relieving colic, acute constipation, and acid reflux. Some researchers have shown that probiotics can help prevent antibiotic-related diarrhea in children, so pediatricians often include probiotic supplements while prescribing antibiotics.
Major players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are emphasizing on new product launches and geographical expansions to meet the growing consumer demand worldwide. They have a widespread global presence, which provides them to serve a large set of customers from all over the world and subsequently increases their market share. These market players focus heavily on new product launches and regional expansions to increase their product range in specialty portfolios.
Infant, Child, and Maternal Probiotic Supplements Market Report Scope
Report Spotlights
- Progressive industry trends in the infant, child, and maternal probiotic supplements market to help companies develop effective long-term strategies
- Business growth strategies adopted by the infant, child, and maternal probiotic supplements market players in developed and developing countries
- Quantitative analysis of the market from 2020 to 2028
- Estimation of global demand for workwear
- Porter’s Five Forces analysis to illustrate the efficacy of buyers and suppliers in the Infant, Child, and Maternal Probiotic Supplements Market
- Recent developments to understand the competitive market scenario
- Market trends and outlook, as well as factors driving and restraining the growth of the Infant, Child, and Maternal Probiotic Supplements Market
- Assistance in the decision-making process by highlighting market strategies that underpin commercial interest
- Size of the infant, child, and maternal probiotic supplements market at various nodes
- A detailed overview and workwear industry dynamics
- Size of the infant, child, and maternal probiotic supplements market in various regions with promising growth opportunities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Form, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, Canada, China, France, Germany, Italy, Japan, Mexico, Middle East and Africa, New Zealand, Russian Federation, South and Central America, United Kingdom, United States
Frequently Asked Questions
Of late, parents have become more concerned about specific nutrition for their children to ensure proper growth and development. According to the World Health Organization (WHO), providing proper nutrition to babies in their first 3 years can reduce mortality and morbidity in them, decrease the risk of chronic diseases throughout their lifetime, and promote regular mental and physical growth. The poor nutrition of infants can cause serious health issues, including stunted growth and malnutrition. Additionally, poor nutrition during the first 3 months of a baby's life can increase the risk of death. However, the rise in awareness regarding proper infant nutrition among parents has reduced the infant mortality rate. Therefore, increase in awareness regarding such nutritional intake has surged the demand for infant, child, and maternal probiotic supplements market.
Based on the end user, maternal women segment is projected to grow at the fastest CAGR over the forecast period. Probiotic supplements are gaining popularity among pregnant women owing to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women in gaining weight.
North America accounted for the largest share of the global workwear market. North America is one of the most significant regions for the infant, child, and maternal probiotic supplements market due to the increasing awareness about the benefits offered by probiotic supplements in infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth. Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the uptake of probiotic supplements.
Based on form, others segment mainly has the largest revenue share. The other forms in the segment include powder, tablets, chewable tablets, effervescent tablets, lozenges, and quick dissolvable formats. The growth is attributed by increasing use of these forms owing to their various benefits such as longer shelf life and physiochemical stability of powder, inexpensive, more effective, and among others. Moreover, such benefits offered by this form have surged manufacturers to in launching probiotic supplements in various forms such as lozenges.
The major players operating in the global infant, child, and maternal probiotic supplements market are Bayer Corporation; Nestle S.A.; Mommy’s Bliss Inc.; LoveBug Probiotics; Biogaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals.
Infant nutrition is one of the most lucrative markets in Asia Pacific. The rising population, steady economic development, and increase in per capita income are some of the major factors driving the infant nutrition market. People in countries such as China, India, and South Korea are highly concerned about their children's health and wellbeing and are widely adopting dietary supplements that support their growth and development. Infant probiotic supplements are also gaining significant traction, owing to children and infants' rising focus on digestive health and immunity. Thus, the rising demand for infant probiotic supplements in developing markets is expected to provide lucrative growth opportunities over the forecast period.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
3.2.8 Limitations and Assumptions:
4. Infant, Child, and Maternal Probiotic Supplements Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis
5. Infant, Child, and Maternal Probiotic Supplements Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
5.3 Market Opportunities
5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints
6. Infant, Child, and Maternal Probiotic Supplements – Global Market Analysis
6.1 Infant, Child, and Maternal Probiotic Supplements Market Overview
6.2 Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
6.3 Competitive Positioning – Key Market Players
7. Infant, Child, And Maternal Probiotic Supplements Market Analysis – By Form
7.1 Overview
7.2 Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
7.3.1 Overview
7.3.2 Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
7.4.1 Overview
7.4.2 Gummies: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
7.5.1 Overview
7.5.2 Liquid: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
7.6.1 Overview
7.6.2 Others: Infant, Child, And Maternal Probiotic Supplements Market– Revenue and Forecast to 2028 (US$ Thousand)
8. Infant, Child, And Maternal Probiotic Supplements Market Analysis – By End User
8.1 Overview
8.2 Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
8.3.1 Overview
8.3.2 Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
8.4.1 Overview
8.4.2 Children: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
8.5.1 Overview
8.5.2 Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9. Infant, Child, and Maternal Probiotic Supplements Market – Geographic Analysis
9.1 Overview
9.2 North America: Infant, Child, and Maternal Probiotic Supplements Market
9.2.1 North America: Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
9.2.2 North America: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.3 North America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4 North America: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.2.4.1 US: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.1.1 US: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.1.2 US: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.2.1 Canada: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.2.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.2.4.3 Mexico: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.4.3.1 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.2.4.3.2 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market
9.3.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
9.3.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.3.4.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.2 UK: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.3 France: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.4 Italy: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.5 Russia: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.3.4.6 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.4.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
9.3.4.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market
9.4.1 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.2 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.3 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
9.4.4.1 China: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.1.1 China: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.1.2 China: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.2.1 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.2.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.3 Australia: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.3.1 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.3.2 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.4 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.4.1 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.4.2 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.4.4.5 Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.4.4.5.1 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.4.4.5.2 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market
9.5.1 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.5.2 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.3 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5.4 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Key Region
9.5.4.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.5.4.1.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.4.1.2 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
9.5.4.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
9.5.4.2.1 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by Form
9.5.4.2.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by End User
10. Industry Landscape
10.1 Overview
10.2 Product launch
10.3 Expansion
11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market
11.1 Impact of COVID-19 on Infant, Child, and Maternal Probiotic Supplements Market
11.2 North America: Impact Assessment of COVID-19 Pandemic
11.3 Europe Impact Assessment of COVID-19 Pandemic
11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.6 South & Central America: Impact Assessment of COVID-19 Pandemic
12. COMPANY PROFILES
12.1 Bayer Corporation
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MaryRuth Organics, LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Mommy’s Bliss Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Pharmavite LLC
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nestlé S.A.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BioGaia AB
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Evolve Biosystems
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lovebug Probiotics
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Biomeology
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Nordic Naturals
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Word Index
LIST OF TABLES
Table 1. Infant, Child, and Maternal Probiotic Supplements Market –Revenue and Forecast to 2028 (US$ Thousand)
Table 2. Global Infant, Child, And Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Global Infant, Child, And Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 4. North America Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. North America Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 6. US Infant, Child, and Maternal Probiotic Supplements Market, Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. US Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Canada Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Canada Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Mexico Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Mexico Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Germany Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Germany Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 16. UK Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 17. UK Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 18. France Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 19. France Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Italy Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 21. Italy Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Russia Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Russia Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, By Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 25. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 26. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 28. China Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 29. China Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 30. Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 31. Japan Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 32. Australia Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 33. Australia Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 34. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 35. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 36. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 37. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 38. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 39. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 40. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 41. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 42. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by Form – Revenue and Forecast to 2028 (US$ Thousand)
Table 43. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by End User – Revenue and Forecast to 2028 (US$ Thousand)
Table 44. List of Abbreviation
LIST OF FIGURES
Figure 1. Infant, Child, and Maternal Probiotic Supplements Market Segmentation
Figure 2. Infant, Child, and Maternal Probiotic Supplements Market Segmentation – By Geography
Figure 3. Global Infant, Child, and Maternal Probiotic Supplements Market Overview
Figure 4. Infant, Child, and Maternal Probiotic Supplements Market: By Form
Figure 5. Infant, Child, and Maternal Probiotic Supplements Market: By Region
Figure 6. Global Infant, Child, and Maternal Probiotic Supplements Market, Key Market Players
Figure 7. Porter's Five Forces Analysis: Infant, Child, and Maternal Probiotic Supplements Market
Figure 8. Expert Opinion
Figure 9. Ecosystem: Infant, Child, and Maternal Probiotic Supplements Market
Figure 10. Infant Mortality Rate: The US, 2010-2020
Figure 11. Global Infant, Child, and Maternal Probiotic Supplements Market Impact Analysis of Drivers and Restraints
Figure 12. Geographic Overview of Infant, Child, and Maternal Probiotic Supplements Market
Figure 13. Global: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 14. Key Players: Infant, Child, and Maternal Probiotic Supplements Market
Figure 15. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 16. Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 17. Gummies: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 18. Liquid: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 19. Others: Infant, Child, And Maternal Probiotic Supplements Market– Revenue and Forecast To 2028 (US$ Thousand)
Figure 20. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By End User (2021 and 2028)
Figure 21. Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 22. Children: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 23. Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market – Revenue and Forecast To 2028 (US$ Thousand)
Figure 24. Global Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Region (2021 and 2028)
Figure 25. North America: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 27. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 28. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 29. US: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Canada: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Mexico: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. Europe: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 33. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
Figure 34. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 35. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 36. Germany: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 37. UK: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 38. France: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 39. Italy: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 40. Russia: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 41. Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 42. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 43. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2021 and 2028)
Figure 44. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 45. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
Figure 46. China: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 47. Japan: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 48. Australia: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 49. New Zealand: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 50. Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 51. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 52. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2020 and 2028)
Figure 53. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
Figure 54. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Region (2021 and 2028)
Figure 55. South and Central America: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 56. Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market–Revenue and Forecast to 2028 (US$ Thousand)
Figure 57. Impact of COVID-19 Pandemic on North America Infant, Child, and Maternal Probiotic Supplements Market
Figure 58. Impact of COVID-19 Pandemic on Europe Infant, Child, and Maternal Probiotic Supplements Market
Figure 59. Impact of COVID-19 Pandemic on Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market
Figure 60. Impact of COVID-19 Pandemic on the Middle East & Africa Infant, Child, and Maternal Probiotic Supplements Market
Figure 61. Impact of COVID-19 Pandemic on South & Central America Infant, Child, and Maternal Probiotic Supplements Market
The List of Companies - Infant, Child, and Maternal Probiotic Supplements Market
- Bayer Corporation
- Nestle S.A.
- Mommy’s Bliss Inc.
- LoveBug Probiotics
- Biogaia AB
- MaryRuth Organics, LLC
- Pharmavite LLC
- Evolve Biosystems
- Biomeology
- Nordic Naturals
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For